Penn State Hershey Pediatric Hematology and Oncology - Clinical Studies - Stem Cell Transplant Studies

Clinical Studies - Stem Cell Transplant Studies

Research Opportunity

Penn State Hershey Children’s Hospital researchers are studying the safety and effectiveness of a vaccine for high risk cancers including:

Neuroblastoma
Osteogenic Sarcoma
Rhabdomyosarcoma

Learn more about this study.

The Use of Umbilical Cord Blood as a Source of Hematopoietic Stem Cells

Status: Active

Investigators:

Kenneth Lucas, M.D.

Categories:

Hematopoietic Stem Cells

A phase I study to examine the toxicity of allogeneic stem cell transplantation for Pediatric solid tumors with relapsed or therapy refractory disease.

Status: Active

Investigators:

Kenneth Lucas, M.D.

Categories:

Allogeneic Stem Cell Transplantation
Pediatric Solid Tumors
Therapy Refractory Disease

A Phase I Trial to Examine the Safety, Clinical, Immunologic and Virologic Effects of CMV pp65 Specific Cytotoxic T Lymphocytes for Recipients of Allogeneic Stem Cell Transplants with Persistent or Therapy Refractory Infections.

Status: Active

Investigators:

Kenneth Lucas, M.D.

Categories:

Allogeneic Stem Cell Transplantation
Therapy Refractory Disease